Nanalysis Announces Management Changes
Nanalysis (NSCIF) appointed Philip Birkby as Interim Chief Financial Officer, effective October 5, 2026, succeeding Heather Kury, whose tenure has concluded.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Nanalysis (NSCIF) appointed Philip Birkby as Interim Chief Financial Officer, effective October 5, 2026, succeeding Heather Kury, whose tenure has concluded.
Birkby is a chartered professional accountant with more than 25 years of experience in public and private organizations, primarily in energy and financial services. His background includes financial reporting, corporate finance, treasury, risk management and corporate governance, along with work with executive teams and boards on liquidity, financing and capital structure.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Philip Birkby, CPA, CA, is a senior finance leader with more than 25 years of experience in publicly traded and private organizations, primarily in the energy and financial services sectors. His experience spans financial reporting, corporate finance, capital allocation, treasury, risk management and corporate governance, and includes working closely with executive leadership teams and Boards on capital structure, liquidity, financing and enterprise risk. Mr. Birkby is a member of the Chartered Professional Accountants of
Mr. Birkby succeeds Heather Kury whose tenure as Chief Financial Officer has concluded. The Board and the entire Nanalysis team would like to thank Ms. Kury for her service and contributions to the Company and wishes her the very best in her future endeavors.
About Nanalysis Scientific Corp. (TSXV: NSCI, FRA: 1N1)
Nanalysis Scientific Corp. develops and manufactures benchtop Nuclear Magnetic Resonance (NMR) spectrometers used worldwide in pharma, biotech, energy, food, materials, and security industries, as well as in academic and government labs. The Company also operates a growing services division that maintains both its own products and third-party imaging equipment, anchored by long-term contract to maintain security scanners at more than 85 Canadian airports.
Notice regarding Forward Looking Information and Legal Disclaimer
This news release contains certain "forward-looking statements" within the meaning of such statements under applicable securities law. Forward-looking statements are frequently characterized by words such as "anticipates", "plan", "continue", "expect", "project", "intend", "believe", "anticipate", "estimate", "may", "will", "potential", "proposed", "positioned" and other similar words, or statements that certain events or conditions "may" or "will" occur. In particular, this news release contains forward-looking information in relation to:: the resignation of the Chief Financial Officer and the appointment of an interim Chief Financial Officer. These statements are only predictions. Various assumptions were used in drawing the conclusions or making the projections contained in the forward-looking statements throughout this news release. Forward-looking statements are based on the opinions and estimates of management at the date the statements are made and are subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those projected in the forward-looking statements. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as expressly required by applicable law.
Neither the TSXV nor its Regulation Services Provider (as that term is defined in policies of the TSXV) accepts responsibility for the adequacy or accuracy of this release.
View original content to download multimedia:https://www.prnewswire.com/news-releases/nanalysis-announces-management-changes-302897983.html
SOURCE Nanalysis Scientific Corp.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
Who is Nanalysis's new interim CFO and when does his appointment take effect?
Philip Birkby was appointed Interim Chief Financial Officer of Nanalysis, effective October 5, 2026. He succeeds Heather Kury, whose tenure as Chief Financial Officer has concluded.